---
$id: https://graph.org.ai/products/commodity/51263126
$type: Product
source: UNSPSC
code: "51263126"
title: "Metipranolol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Metipranolol

**UNSPSC Code**: 51263126
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C17H27NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X39AL81KEB, chemically known as 4-(2-hydroxy-3-((1-methylethyl)-amino)propoxy)-2,3,6-trimethylphenol 1-acetate but generally known as metipranolol, which bears US NIH Compound Identifier 31477. European Medicines Agency schedules Metipranolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08892MIG. The term METIPRANOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules metipranolol in its Anatomical Therapeutic Chemical (ATC) Classification. METIPRANOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metipranolol under HS 29221980 and SITC 51461. As of Q4 2014, METIPRANOLOL remains the US FDA Preferred Term for this commodity. Metipranolol bears US NLM identifiers UMLS ID C0041030 and NCI Concept Code C61844. SMILES: O(CC(O)CNC(C)C)C1C(C(C(OC(=O)C)C(C1)C)C)C.

